SCOPUS 정보 검색 플랫폼

Volumn 7, Issue 9, 2001, Pages 2854-2861

Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers

(7) Szepeshazi, K a Schally, A V a Halmos, G a Sun, B a Hebert, F a Csernus, B a Nagy, A a

a VETERANS AFFAIRS MEDICAL CENTER (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PYRROLINODOXORUBICIN; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLLYSYLVALYLCYSTEINYLTHREONINAMIDE 2,7 DISULFIDE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLLYSYLVALYLCYSTEINYLTHREONINAMIDE 2,7 DISULFIDE 2 PYRROLINODOXORUBICIN; MESSENGER RNA; RECEPTOR SUBTYPE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 5; UNCLASSIFIED DRUG; VAPREOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG TARGETING; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BINDING, COMPETITIVE; CELL DIVISION; DOXORUBICIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PANCREATIC NEOPLASMS; PYRROLES; RECEPTORS, SOMATOSTATIN; RNA, MESSENGER; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0034803184 PISSN: 10780432 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (43)

References (46)

1
- 0031855524
- Advances in the treatment of patients with pancreatic cancer: Improvement in symptoms and survival time
- (1998) Br. J. Cancer , vol.78 , Issue.SUPPL. 3 , pp. 9-13
- Von Hoff, D.D.¹ Goodwin, A.L.² Garcia, L.³

2
- 0029036704
- Pancreatic cancer: A plea for more trials
- (1995) Eur. J. Cancer , vol.31 , pp. 867-869
- Van Cutsem, E.¹ Fevery, J.²

3
- 0033959520
- Cancer Statistics 2000
- (2000) CA Cancer J. Clin. , vol.50 , pp. 7-33
- Greenlee, R.T.¹ Murray, T.² Bolden, S.³ Wingo, P.A.⁴

4
- 0000702133
- Hypothalamic and other peptide hormones
- J. F. Holland, E. Frei III, R. C. Bast, Jr., D. E. Kufe, R. E. Pollock, and R. R. Weichselbaum (eds.). Hamilton, Ontario: B. C. Decker, Inc.
- (2000) Cancer Medicine, 5th ed. , pp. 715-729
- Schally, A.V.¹ Comaru-Schally, A.M.²

5
- 0031941299
- Mechanism of antineoplastic action of somatostatin analogs
- (1998) Proc. Soc. Exp. Biol. Med. , vol.217 , pp. 143-152
- Pollak, M.N.¹ Schally, A.V.²

6
- 0027818856
- Somatostatin analogs for diagnosis and treatment of cancer
- (1993) Pharmacol. Ther. , vol.60 , pp. 245-264
- Weckbecker, G.¹ Raulf, F.² Stolz, B.³ Bruns, C.⁴

7
- 0031412395
- Somatostatin receptors
- (1997) Trends Endocrinol. Metab. , vol.8 , pp. 398-405
- Patel, Y.C.¹ Srikant, C.B.²

8
- 0027517429
- 3]-octreotide: The Rotterdam experience with more than 1000 patients
- (1993) Eur. J. Nucl. Med. , vol.20 , pp. 716-731
- Krenning, E.P.¹ Kwekkeboom, D.J.² Bakker, W.H.³ Breeman, W.A.P.⁴ Kooij, P.P.M.⁵ Oei, H.Y.⁶ Van Hagen, M.⁷ Postema, P.T.E.⁸ De Jong, M.⁹ Reubi, J.C.¹⁰ Visser, T.J.¹¹ Reijs, A.E.M.¹² Hofl, L.J.¹³ Koper, J.W.¹⁴ Lamberts, S.W.J.¹⁵

9
- 0003438265
- Somatostatin receptor expression: Therapeutic considerations
- (1997) J. Endocrinol. Investig. , vol.20 , Issue.SUPPL. 7 , pp. 2-4
- Bruns, C.¹ Stolz, B.² Raulf, F.³ Schloss, J.⁴ Weckbecker, G.⁵

10
- 0032492168
- Yttrium-90-labelled somatostatin-analogue for cancer treatment
- (1998) Lancet , vol.351 , pp. 417-418
- Otte, A.¹ Muller-Brand, J.² Dellas, S.³ Nitzsche, E.U.⁴ Herrmann, R.⁵ Maecke, H.R.⁶

11
- 0032900726
- 3octreotide (DOTATOC): A pilot study in human gliomas
- (1999) Clin. Cancer Res. , vol.5 , pp. 1025-1033
- Merlo, A.¹ Hausmann, O.² Wasner, M.³ Steiner, P.⁴ Otte, A.⁵ Jermann, E.⁶ Freitag, P.⁷ Reubi, J.C.⁸ Müller-Brand, J.⁹ Gratzl, O.¹⁰ Macke, H.R.¹¹

12
- 0034033495
- Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use
- (2000) Eur. J. Nucl. Med. , vol.27 , pp. 273-282
- Reubi, J.C.¹ Schär, J.C.² Waser, B.³ Wenger, S.⁴ Heppeler, A.⁵ Schmitt, J.S.⁶ Mäcke, H.R.⁷

13
- 9244237087
- Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer
- (1996) Cancer Res. , vol.56 , pp. 1823-1827
- Buscail, L.¹ Saint-Laurent, N.² Chastre, E.³ Vaillant, J.-C.⁴ Gespach, C.⁵ Capella, G.⁶ Kalthoff, H.⁷ Lluis, F.⁸ Vaysse, N.⁹ Susini, C.¹⁰

14
- 0031025637
- sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells
- (1997) Cancer Res. , vol.57 , pp. 956-962
- Delesque, N.¹ Buscail, L.² Esteve, J.-P.³ Saint-Laurent, N.⁴ Muller, C.⁵ Weckbecker, G.⁶ Bruns, C.⁷ Vaysse, N.⁸ Susini, C.⁹

15
- 0032542522
- Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer
- (1998) J. Natl. Cancer Inst. (Bethesda) , vol.90 , pp. 322-324
- Fisher, W.E.¹ Doran, T.A.² Muscarella, P.I.I.³ Boros, L.G.⁴ Ellison, E.C.⁵ Schirmer, W.J.⁶

16
- 0032483743
- Expression of human somatostatin receptor subtype 3 in pancreatic cancer in vitro and in vivo
- (1998) J. Natl. Cancer Inst. (Bethesda) , vol.90 , pp. 1666-1668
- Raderer, M.¹ Pangerl, T.² Leimer, M.³ Valencak, J.⁴ Kurtaran, A.⁵ Hamilton, G.⁶ Scheithauer, W.⁷ Virgolini, I.⁸

17
- 0032478995
- Re: Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer
- (1998) J. Natl. Cancer Inst. (Bethesda) , vol.90 , pp. 864-865
- Buscail, L.¹

18
- 0029822870
- Expression of the somatostatin receptor subtype-2 gene predicts response of human pancreatic cancer to octreotide
- (1996) Surgery (St. Louis) , vol.120 , pp. 234-240
- Fisher, W.E.¹ Muscarela, P.² O'Dorisimo, T.M.³ O'Dorisimo, M.S.⁴ Kim, J.A.⁵ Doran, T.A.⁶ Sabourin, C.L.⁷ Schirmer, W.J.⁸

19
- 0032950730
- Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: In vitro and in vivo results. Br
- (1999) Br. J. Cancer , vol.79 , pp. 535-537
- Raderer, M.¹ Hamilton, G.² Kurtaran, A.³ Valencak, J.⁴ Hoffman, O.⁵ Kornek, G.V.⁶ Vorbeck, F.⁷ Hejna, M.H.L.⁸ Virgolini, I.⁹ Scheithauer, W.¹⁰

20
- 0031869490
- Immunohistochemical localization of somatostatin receptors sst2A in human tumors
- (1998) Am. J. Pathol. , vol.153 , pp. 233-245
- Reubi, J.C.¹ Kappeler, A.² Waser, B.³ Laissue, J.⁴ Hipkin, R.W.⁵ Schonbrunn, A.⁶

21
- 0032539609
- Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolino-doxorubicin
- (1998) Proc. Natl. Acad. Sci. USA , vol.95 , pp. 1794-1799
- Nagy, A.¹ Schally, A.V.² Halmos, G.³ Armatis, P.⁴ Cai, R.-Z.⁵ Csernus, V.⁶ Kovacs, M.⁷ Koppan, M.⁸ Szepeshazi, K.⁹ Kahan, Z.¹⁰

22
- 0032797051
- Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors
- (1999) Eur. J. Endocrinol. , vol.141 , pp. 1-14
- Schally, A.¹ Nagy, A.²

23
- 0032530629
- Targeted cytotoxic analog of somatostatin AN-238 inhibits growth of androgen independent Dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses
- (1998) Cancer Res. , vol.58 , pp. 4132-4137
- Koppan, M.¹ Nagy, A.² Schally, A.V.³ Arencibia, J.M.⁴ Plonowski, A.⁵ Halmos, G.⁶

24
- 0033561724
- Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238
- (1999) Cancer Res. , vol.59 , pp. 1947-1953
- Plonowski, A.¹ Schally, A.V.² Nagy, A.³ Sun, B.⁴ Szepeshazi, K.⁵

25
- 0032816763
- Inhibition of growth of MX-1, MCF-7-MIII and MDAMB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238
- (1999) Int. J. Cancer , vol.82 , pp. 592-598
- Kahan, Z.¹ Nagy, A.² Schally, A.V.³ Hebert, F.⁴ Sun, B.⁵ Groot, K.⁶ Halmos, G.⁷

26
- 0034212905
- Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238
- (2000) Cancer Res. , vol.60 , pp. 2996-3001
- Plonowski, A.¹ Schally, A.V.² Nagy, A.³ Kiaris, H.⁴ Hebert, F.⁵ Halmos, G.⁶

27
- 0033981859
- Regression of U-87 human glioblastomas in nude mice after treatment with a cytotoxic somatostatin analog AN-238
- (2000) Clin. Cancer Res. , vol.6 , pp. 709-717
- Kiaris, H.¹ Schally, A.V.² Nagy, A.³ Sun, B.⁴ Szepeshazi, K.⁵ Halmos, G.⁶

28
- 0007296407
- Synthesis and biological activity of highly potent octapeptide analogs of somatostatin
- (1986) Proc. Natl. Acad. Sci. USA , vol.83 , pp. 1896-1900
- Cai, R.-Z.¹ Szoke, B.² Lu, R.³ Fu, D.⁴ Redding, T.W.⁵ Schally, A.V.⁶

29
- 0029965293
- High-yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent; structure-activity relationship of daunosamine-modified derivatives of doxorubicin
- (1996) Proc. Natl. Acad. Sci. USA , vol.93 , pp. 2464-2469
- Nagy, A.¹ Armatis, P.² Schally, A.V.³

30
- 0033963319
- Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumors
- (2000) Eur. J. Cancer , vol.36 , pp. 128-136
- Szepeshazi, K.¹ Schally, A.V.² Groot, K.³ Armatis, P.⁴ Hebert, F.⁵ Halmos, G.⁶

31
- 0020616606
- Establishment and characterization of human pancreatic adenocarcinoma cell line SW-1990 in tissue culture and the nude mice
- (1983) Cancer Res. , vol.43 , pp. 4393-4401
- Kyriazis, A.P.¹ McCombs III, W.B.² Sandberg, A.A.³ Kyriazis, A.A.⁴ Sloane, N.H.⁵ Lepera, R.⁶

32
- 0034457915
- High expression of somatostatin receptors and messenger ribonucleic acid for its receptor subtypes in organ-confined and locally advanced human prostate cancers
- (2000) J. Clin. Endocrinol. Metab. , vol.85 , pp. 2564-2571
- Halmos, G.¹ Schally, A.V.² Sun, B.³ Davis, R.⁴ Bostwick, D.G.⁵ Plonowski, A.⁶

33
- 0033756778
- Human ovarian cancers express somatostatin receptors
- (2000) J. Clin. Endocrinol. Metab. , vol.85 , pp. 3509-3512
- Halmos, G.¹ Sun, B.² Schally, A.V.³ Hebert, F.⁴ Nagy, A.⁵

34
- 0030994858
- 5 expression in human pituitary, gastroentero-pancreatic and mammary tumors: Comparison of mRNA analysis with receptor autoradiography
- (1997) Int. J. Cancer , vol.70 , pp. 530-537
- Schaer, J.C.¹ Waser, B.² Mengod, G.³ Reubi, J.C.⁴

35
- 0030752863
- Different expression patterns of somatostatin receptor subtypes in cultured epithelial cells from human normal prostate and prostate cancer
- (1997) J. Clin. Endocrinol. Metab. , vol.82 , pp. 25662569
- Sinisi, A.A.¹ Bellastella, A.² Prezioso, D.³ Nicchio, M.R.⁴ Lotti, T.⁵ Salvatore, M.⁶ Pasquali, D.⁷

36
- 17444441370
- 3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies
- (1998) Clin. Cancer Res. , vol.4 , pp. 2047-2052
- Schulz, S.¹ Schulz, S.² Schmitt, J.³ Wiborny, D.⁴ Schmidt, H.⁵ Olbricht, S.⁶ Weise, W.⁷ Roessner, A.⁸ Gramsch, C.⁹ Höllt, V.¹⁰

37
- 0024437217
- Membrane receptors for peptides in experimental and human pancreatic cancers
- (1989) Pancreas , vol.4 , pp. 521-528
- Fekete, M.¹ Zalatnai, A.² Comaru-Schally, A.M.³ Schally, A.V.⁴

38
- 0025306191
- Evaluation of receptors for somatostatin in various tumors using different analogs
- (1990) J. Clin. Endocrinol. Metab. , vol.70 , pp. 661-669
- Srkalovic, G.¹ Cai, R.-Z.² Schally, A.V.³

39
- 0031769476
- Immunohistochemical localization of somatostatin receptor sst2A in human pancreatic islets
- (1998) J. Clin. Endocrinol. Metab. , vol.83 , pp. 3746-3749
- Reubi, J.C.¹ Kappeler, A.² Waser, B.³ Schonbrunn, A.⁴ Laissue, J.⁵

40
- 0032893138
- Expression of somatostatin receptors in peritumoral veins of human tumors
- (1999) Cancer (Phila.) , vol.85 , pp. 188-198
- Denzler, B.¹ Reubi, J.C.²

41
- 2642657309
- Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829
- (1998) Cancer Res. , vol.58 , pp. 1850-1859
- Virgolini, I.¹ Leimer, M.² Handmaker, H.³ Lastoria, S.⁴ Bischof, C.⁵ Muto, P.⁶ Pengerl, T.⁷ Gludovacz, D.⁸ Peck-Radosavljevic, M.⁹ Lister-James, J.¹⁰ Hamilton, G.¹¹ Kaserer, K.¹² Valent, P.¹³ Dean, R.¹⁴

42
- 0033178707
- Differential regulation of somatostatin receptor type 2 (sst2) expression in AR4-2J tumor cells implanted into mice during octreotide treatment
- (1999) Cancer Res. , vol.59 , pp. 3652-3657
- Froidevaux, S.¹ Hinatermann, E.² Török, M.³ Macke, H.R.⁴ Beglinger, C.⁵ Eberle, A.N.⁶

43
- 0034681171
- Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: Implications for the design of preclinical studies
- (2000) Proc. Natl. Acad. Sci. USA , vol.97 , pp. 829-834
- Nagy, A.¹ Plonowski, A.² Schally, A.V.³

44
- 0344500650
- A Phase II study of high-dose octreotide in patients with unresectable pancreatic carcinoma
- (1999) Eur. J. Cancer , vol.35 , pp. 1805-1808
- Sulkowski, U.¹ Büchler, M.² Pederzoli, P.³ Arnold, R.⁴ Dinse, P.⁵ Kay, A.⁶ Haus, U.⁷ Beget, H.G.⁸

45
- 0033822686
- Phase III Evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: A North Central Cancer Treatment Group Study
- (2000) Clin. Cancer Res. , vol.6 , pp. 3486-3492
- Burch, P.A.¹ Block, M.² Schroeder, G.³ Kugler, J.W.⁴ Sargent, D.J.⁵ Braich, T.A.⁶ Mailliard, J.A.⁷ Michalak, J.C.⁸ Hatfield, A.K.⁹ Wright, K.¹⁰ Kuross, S.A.¹¹

46
- 0034986641
- Targeted cytotoxic somatostatin analogs: A modern approach to the therapy of various cancers
- (2001) Drugs Future , vol.26 , pp. 261-270
- Nagy, A.¹ Schally, A.V.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.